Inhibition of p53 by Adenovirus Type 12 E1B-55K Deregulates Cell Cycle Control and Sensitizes Tumor Cells to Genotoxic Agents

Abstract

Adenovirus E1B-55K represses p53-mediated transcription. However, the phenotypic consequence of p53 inhibition by E1B-55K for cell cycle regulation and drug sensitivity in tumor cells has not been examined. In HCT116 cells with constitutive E1B-55K expression, the activation of p53 target genes such as the p21, Mdm2, and Puma genes was attenuated, despite markedly elevated p53 protein levels. HCT116 cells with E1B-55K expression displayed a cell cycle profile similar to that of the isogenic HCT116p53 ؊/؊ cells, including unhindered S-phase entry despite DNA damage. Surprisingly, E1B-55K-expressing cells were more sensitive to drug treatment than parental cells. Compared to HCT116 cells, HCT116p53؊/؊ cells were more susceptible to both doxorubicin and etoposide, and E1B-55K expression had no effects on drug treatment. E1B-55K expression increased the rate of cell proliferation in HCT116 but not in HCT116p53؊/؊ cells. Thus, deregulation of p53-mediated cell cycle control by E1B-55K probably underlies sensitization of HCT116 cells to anticancer drugs. Consistently, E1B-55K expression in A549, A172, and HepG2 cells, all containing wild-type (wt) p53, also enhanced etoposide-induced cytotoxicity, whereas in p53-null H1299 cells, E1B-55K had no effects. We generated several E1B-55K mutants with mutations at positions occupied by the conserved Phe/Trp/His residues. Most of these mutants showed no or reduced binding to p53, although some of them could still stabilize p53, suggesting that binding might not be essential for E1B-55K-induced p53 stabilization. Despite heightened p53 protein levels in cells expressing certain E1B-55K mutants, p53 activity was largely suppressed. Furthermore, most of these E1B-55K mutants could sensitize HCT116 cells to etoposide and doxorubicin. These results indicate that E1B-55K might have utility for enhancing chemotherapy.

Small-Molecule Inhibitors of Acetyltransferase p300 Identified by High-Throughput Screening Are Potent Anticancer Agents

“…Cell viability and cell cycle assays were done as described (22). In colony formation assay, cells were seeded in 6-well plates and exposed to various concentrations of L002 for 48 h. The treated cells were trypsinized and 3,500 cells per well were reseeded.…”

Identification of Histone Deacetylase Inhibitors with Benzoylhydrazide Scaffold that Selectively Inhibit Class I Histone Deacetylases

“…MDA-MB-231 cells were treated with DMSO, UF010 or vorinostat for 24 h. Cells were fixed and subject to cell cycle analysis using fluorescence activated cell sorting (FACS) as described (Li, et al, 2011). For cell migration assays, a confluent monolayer culture of MDA-MB-231 cells was pretreated with DMSO, vorinostat or UF010 for 2 h. The cells were scratched with a pipette tip and the “wounded” areas were imaged at various time points.…”

Intrinsic cellular signaling mechanisms determine the sensitivity of cancer cells to virus-induced apoptosis

“…Flow cytometry of control and virus-infected cells was done as described previously55. The viability of cells infected with viruses or treated with an inhibitor was determined using the CellTiter-Glo kit (Promega) as published56.…”